Cardiac insulin resistance and microRNA modulators
- PMID: 21977024
- PMCID: PMC3184440
- DOI: 10.1155/2012/654904
Cardiac insulin resistance and microRNA modulators
Abstract
Cardiac insulin resistance is a metabolic and functional disorder that is often associated with obesity and/or the cardiorenal metabolic syndrome (CRS), and this disorder may be accentuated by chronic alcohol consumption. In conditions of over-nutrition, increased insulin (INS) and angiotensin II (Ang II) activate mammalian target for rapamycin (mTOR)/p70 S6 kinase (S6K1) signaling, whereas chronic alcohol consumption inhibits mTOR/S6K1 activation in cardiac tissue. Although excessive activation of mTOR/S6K1 induces cardiac INS resistance via serine phosphorylation of INS receptor substrates (IRS-1/2), it also renders cardioprotection via increased Ang II receptor 2 (AT2R) upregulation and adaptive hypertrophy. In the INS-resistant and hyperinsulinemic Zucker obese (ZO) rat, a rodent model for CRS, activation of mTOR/S6K1signaling in cardiac tissue is regulated by protective feed-back mechanisms involving mTOR↔AT2R signaling loop and profile changes of microRNA that target S6K1. Such regulation may play a role in attenuating progressive heart failure. Conversely, alcohol-mediated inhibition of mTOR/S6K1, down-regulation of INS receptor and growth-inhibitory mir-200 family, and upregulation of mir-212 that promotes fetal gene program may exacerbate CRS-related cardiomyopathy.
Figures




Similar articles
-
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.Endocrinology. 2005 Mar;146(3):1473-81. doi: 10.1210/en.2004-0921. Epub 2004 Dec 16. Endocrinology. 2005. PMID: 15604215
-
Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.J Biol Chem. 2011 May 27;286(21):18465-73. doi: 10.1074/jbc.M110.200022. Epub 2011 Apr 8. J Biol Chem. 2011. PMID: 21478152 Free PMC article.
-
Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.Int J Biochem Cell Biol. 2015 Jul;64:25-33. doi: 10.1016/j.biocel.2015.03.006. Epub 2015 Mar 23. Int J Biochem Cell Biol. 2015. PMID: 25813876
-
Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R885-95. doi: 10.1152/ajpregu.00316.2011. Epub 2011 Aug 3. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21813874 Free PMC article. Review.
-
Overnutrition, mTOR signaling, and cardiovascular diseases.Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1198-206. doi: 10.1152/ajpregu.00262.2014. Epub 2014 Sep 24. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 25253086 Free PMC article. Review.
Cited by
-
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies.Acta Pharmacol Sin. 2025 Jun;46(6):1539-1555. doi: 10.1038/s41401-025-01476-z. Epub 2025 Feb 5. Acta Pharmacol Sin. 2025. PMID: 39910210 Review.
-
Potential biofluid markers and treatment targets for renal cell carcinoma.Nat Rev Urol. 2013 Jun;10(6):336-44. doi: 10.1038/nrurol.2013.52. Epub 2013 Apr 2. Nat Rev Urol. 2013. PMID: 23545813 Review.
-
Insulin resistance and heart failure: molecular mechanisms.Heart Fail Clin. 2012 Oct;8(4):609-17. doi: 10.1016/j.hfc.2012.06.005. Epub 2012 Aug 9. Heart Fail Clin. 2012. PMID: 22999243 Free PMC article. Review.
-
The two faces of miR-29.J Cardiovasc Med (Hagerstown). 2015 Jul;16(7):480-90. doi: 10.2459/JCM.0000000000000246. J Cardiovasc Med (Hagerstown). 2015. PMID: 25689084 Free PMC article. Review.
-
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.Cardiorenal Med. 2012 May;2(2):87-109. doi: 10.1159/000335675. Epub 2012 Feb 7. Cardiorenal Med. 2012. PMID: 22619657 Free PMC article.
References
-
- Sowers JR. Hypertension, angiotensin II, and oxidative stress. The New England Journal of Medicine. 2002;346(25):1999–2001. - PubMed
-
- Sowers JR. Metabolic risk factors and renal disease. Kidney International. 2007;71(8):719–720. - PubMed
-
- Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine. 2006;119(10):812–819. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous